- Home
- ICCC vs FBLG Comparison
ICCC vs FBLG Comparison
Compare ICCC & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- FBLG
- Stock Information
- Founded
- ICCC 1982
- FBLG 2021
- Country
- ICCC United States
- FBLG United States
- Employees
- ICCC N/A
- FBLG N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- ICCC Health Care
- FBLG
- Exchange
- ICCC Nasdaq
- FBLG NYSE
- Market Cap
- ICCC 39.2M
- FBLG 37.1M
- IPO Year
- ICCC 1987
- FBLG 2024
- Fundamental
- Price
- ICCC $4.94
- FBLG $0.98
- Analyst Decision
- ICCC
- FBLG Strong Buy
- Analyst Count
- ICCC 0
- FBLG 4
- Target Price
- ICCC N/A
- FBLG $13.00
- AVG Volume (30 Days)
- ICCC 10.9K
- FBLG 143.6K
- Earning Date
- ICCC 05-13-2025
- FBLG 05-13-2025
- Dividend Yield
- ICCC N/A
- FBLG N/A
- EPS Growth
- ICCC N/A
- FBLG N/A
- EPS
- ICCC N/A
- FBLG N/A
- Revenue
- ICCC $26,493,000.00
- FBLG N/A
- Revenue This Year
- ICCC N/A
- FBLG N/A
- Revenue Next Year
- ICCC N/A
- FBLG $235.70
- P/E Ratio
- ICCC N/A
- FBLG N/A
- Revenue Growth
- ICCC 51.63
- FBLG N/A
- 52 Week Low
- ICCC $3.34
- FBLG $0.95
- 52 Week High
- ICCC $5.82
- FBLG $13.59
- Technical
- Relative Strength Index (RSI)
- ICCC 48.48
- FBLG 36.42
- Support Level
- ICCC $4.56
- FBLG $0.95
- Resistance Level
- ICCC $5.05
- FBLG $1.16
- Average True Range (ATR)
- ICCC 0.23
- FBLG 0.08
- MACD
- ICCC 0.01
- FBLG 0.01
- Stochastic Oscillator
- ICCC 80.51
- FBLG 5.05
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.